media

Insights

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
News

Global IP Spotlight – Latin America

On-demand Global IP Spotlight briefing on Latin America covering AI, SEPs, pharmaceuticals, patent prosecution and oppositions, with takeaways for U.S. stakeholders.
2026
2
min read
Patent Litigation & Enforcement
Patent Litigation & Enforcement

SEP Litigation in Brazil: Five Big Developments in 2025

Brazil's 2025 SEP litigation experienced significant growth, with Rio courts becoming a key forum, marked by procedural innovations, FRAND emphasis, and emerging connected-car disputes.
2026
9
min read
News
News

Fulbright's IPO thwarted by patent cases

Fulbright Medical’s Shanghai Stock Exchange IPO was terminated after extensive Johnson & Johnson patent litigation, including multiple infringement suits and rising damages claims.
2024
2
min read
CIP today
News
News

26th Berkeley-Stanford APLI: (Day 1, Panel 7) Injunctive Relief

Program listing for APLI Day 1 Panel 7 on injunctive relief, covering a global perspective for enforcing patents and building portfolios.
2026
1
min read
News
News

UPC’s first Brazilian plaintiff wins PI in parallel Munich proceedings

Silimed secured a Munich PI against Polytech over EP2581193, halting polyurethane-coated implant manufacture and sales in Germany amid parallel UPC action.
2026
3
min read
Olivia Sophie Rafferty
News
News

São Paulo Court Grants Johnson & Johnson Extraordinary Emergency Relief and Reinstates Injunction in Med Tech Patent Dispute

São Paulo Court of Justice reinstated an injunction in a med-tech patent dispute, granting suspensive effect to J&J’s extraordinary appeals against Scitech.
2026
4
min read
News
News

[Part 2] China's domestic replacement of high-end medical andsurgical instruments faces temporary ban from Brazil

São Paulo court restored a temporary injunction in Johnson & Johnson v Scitech, reimposing Brazil’s ban on sales of Altus electric staplers.
2026
4
min read
Lu Yuer
News
News

[Part 1] 161 million! China's domestic substitution of high-endmedical and surgical instruments has collectivelyencountered patent blocking

David Medical and its subsidiary face Silag/Johnson & Johnson patent suits in China, with claimed damages raised to RMB 161.26 million.
2026
4
min read
Lu Yuer
News
News

BRPTO Study Maps Patent Activity in Satellite Energy and Space Propulsion Technologies

BRPTO’s 2026 patent landscape maps satellite energy and space propulsion trends, showing Brazil’s growing filings and the dominance of research institutions.
2026
5
min read
News
News

First Brazilian UPC claimant: Silimed sues Polytech in Hamburg over implant technology

Silimed becomes the first Brazilian UPC claimant, suing Polytech in Hamburg over EP’193 implant technology and seeking pan‑European injunctive relief.
2026
3
min read
News
News

UPC receives first Brazilian claimant: Silimed sues Polytech for patent infringement

Silimed becomes the first Brazilian claimant at the UPC, suing Polytech in Hamburg over EP2581193 and building on German entitlement wins.
2026
2
min read
Anushka Sharma
Patent Litigation & Enforcement
Patent Litigation & Enforcement

Attached ruling | ZTE is again upheld by an injunction from the Brazilian Court of Appeal

The Brazilian Court of Appeal has upheld a preliminary injunction for ZTE against Samsung, reinforcing patent exclusivity in 5G Standard Essential Patent disputes.
2026
3
min read
Intellectual Property Frontier
News
News

Roche’s Genentech, Organon and Henlius Settle Pertuzumab Biosimilar Disputes Across the U.S., UPC, the Netherlands and Brazil

Global settlement of pertuzumab biosimilar disputes across the U.S., UPC, the Netherlands and Brazil, highlighting Brazil’s key validity win and UPC order.
2026
5
min read
RNA Law Editorial
News
News

BRPTO's Patent Data Maps Green Innovation in Agriculture

This BRPTO study analyzes 6,300 patent applications to map green innovation in Brazilian agriculture, highlighting biofertilizers and international cooperation.
2026
4
min read